|
Coagulation Disorders
Citations 1-10 of 34 total displayed.
|
Most recent content
(23 Nov 2009):
|
- Original Investigations
Yield of Bone Marrow Examination in Diagnosing the Source of Fever of Unknown Origin
- Arnaud Hot; Isabelle Jaisson; Charlotte Girard; Martine French; Denis Vital Durand; Hugues Rousset; Jacques Ninet
Arch Intern Med 2009; 169: 2018-2023.
[Abstract]
[Full text]
[PDF]
|
Past content
(since Oct 1998):
|
- Original Investigations
Risk of Immune Thrombocytopenic Purpura and Autoimmune Hemolytic Anemia Among 120 908 US Veterans With Hepatitis C Virus Infection
- Elizabeth Y. Chiao; Eric A. Engels; Jennifer R. Kramer; Kenneth Pietz; Louise Henderson; Thomas P. Giordano; Ola Landgren
Arch Intern Med 2009; 169: 357-363.
[Abstract]
[Full text]
[PDF]
- Editor's Correspondence
Heparin and Thrombocytopenia: Guilty Till Proven Innocent?
- Harris V. K. Naina; Samar Harris
Arch Intern Med 2008; 168: 2169-a-2170-a.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Risk Factors for Thrombocytopenia in Patients Treated With Prolonged Heparin Therapy
- David R. Williamson; Danielle Pilon
Arch Intern Med 2008; 168: 2170-a-2171-a.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Incidence and Prognostic Significance of Thrombocytopenia in Patients Receiving Heparin Therapy
- Weekitt Kittisupamongkol
Arch Intern Med 2008; 168: 2170.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Risk Factors for Thrombocytopenia in Patients Treated With Prolonged Heparin Therapy—Reply
- Christopher B. Granger; E. Magnus Ohman; Richard C. Becker
Arch Intern Med 2008; 168: 2171.
[Extract]
[Full text]
[PDF]
- Review Articles
Low-Molecular-Weight Heparin vs Unfractionated Heparin for Perioperative Thromboprophylaxis in Patients With Cancer: A Systematic Review and Meta-analysis
- Elie A. Akl; Irene Terrenato; Maddalena Barba; Francesca Sperati; Elena V. Sempos; Paola Muti; Deborah J. Cook; Holger J. Schünemann
Arch Intern Med 2008; 168: 1261-1269.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Incidence and Prognostic Significance of Thrombocytopenia in Patients Treated With Prolonged Heparin Therapy
- Gustavo B. F. Oliveira; Eric M. Crespo; Richard C. Becker; Emily F. Honeycutt; Charles S. Abrams; Kevin J. Anstrom; Peter B. Berger; Linda D. Davidson-Ray; Eric L. Eisenstein; Neal S. Kleiman; David J. Moliterno; Stephan Moll; Lawrence Rice; Jo E. Rodgers; Steven R. Steinhubl; Victor F. Tapson; E. Magnus Ohman; Christopher B. Granger; for the Complications After Thrombocytopenia Caused by Heparin (CATCH) Registry Investigators
Arch Intern Med 2008; 168: 94-102.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Long-term Outcome of 231 Patients With Essential Thrombocythemia: Prognostic Factors for Thrombosis, Bleeding, Myelofibrosis, and Leukemia
- Chor-Sang Chim; Yok-Lam Kwong; Albert Kwok-Wei Lie; Siu-Kwan Ma; Chi-Chung Chan; Lap-Gate Wong; Bonnie Chi San Kho; Harold-Kwok Lee; Joycelyn Pui-Yin Sim; Cheuk-Hung Chan; Joyce Chee-Wun Chan; Yiu-Ming Yeung; Martin Law; Raymond Liang
Arch Intern Med 2005; 165: 2651-2658.
[Abstract]
[Full text]
[PDF]
- Commentaries
Heparin-Induced Thrombocytopenia: Myths and Misconceptions (That Will Cause Trouble for You and Your Patient)
- Lawrence Rice
Arch Intern Med 2004; 164: 1961-1964.
[Extract]
[Full text]
[PDF]
|
|
